Blistering

DGAP-News: Medios significantly expands its market position in manufacturing with the acquisition of NewCo Pharma Group and taps new growth potentials

Thursday, November 25, 2021 - 12:06pm

Berlin, November 25, 2021 - Medios AG ("Medios"), the leading provider of Specialty Pharma Solutions in Germany, has today entered into a purchase agreement to acquire the specialized pharmaceutical manufacturer NewCo Pharma GmbH ("NewCo Pharma"), Mannheim.

Key Points: 
  • Berlin, November 25, 2021 - Medios AG ("Medios"), the leading provider of Specialty Pharma Solutions in Germany, has today entered into a purchase agreement to acquire the specialized pharmaceutical manufacturer NewCo Pharma GmbH ("NewCo Pharma"), Mannheim.
  • The acquisition of NewCo Pharma enables Medios to significantly strengthen in particular the segment of patient-specific therapies and thus also to significantly and sustainably increase the profit margins of the entire Medios Group.
  • Matthias Gaertner, CEO of Medios AG: "The acquisition of NewCo Pharma is a major milestone in Medios' sustainable growth strategy.
  • Together with NewCo Pharma, we aim to exceed the 1.5-billion-euro revenue mark in 2022 and significantly increase our EBITDA pre1 margin to over 3%.

DGAP-News: Medios AG: Sales more than doubled in the first nine months of 2021 - disproportionate increase in earnings

Tuesday, October 26, 2021 - 12:11pm

Berlin, October 26, 2021 - Medios AG ("Medios"), the leading provider of Specialty Pharma Solutions in Germany, grew strongly in the first nine months of the 2021 financial year.

Key Points: 
  • Berlin, October 26, 2021 - Medios AG ("Medios"), the leading provider of Specialty Pharma Solutions in Germany, grew strongly in the first nine months of the 2021 financial year.
  • EBITDA pre1 rose to 28.1 million (previous year 10.2 million), an increase of 174.7%.
  • Matthias Gaertner, CEO of Medios AG: "In the first nine months, we have increased our sales to almost one billion euros.
  • Medios expects strong growth in the 2021 financial year despite the continued challenging market environment and confirms its sales guidance.

Therapon Skin Health Unveils Cool Skin, A Hero Product, Under The Theraderm Brand

Monday, October 25, 2021 - 11:57am

SPRINGDALE, Ark., Oct. 25, 2021 /PRNewswire/ --Therapon Skin Health, the makers of the medical-grade skin care line, Theraderm Clinical Skin Care , announces the re-launch of one of its foundational products, Theraderm Cool Skin .

Key Points: 
  • SPRINGDALE, Ark., Oct. 25, 2021 /PRNewswire/ --Therapon Skin Health, the makers of the medical-grade skin care line, Theraderm Clinical Skin Care , announces the re-launch of one of its foundational products, Theraderm Cool Skin .
  • Previously known as Instant Cool Skin under the Therapon brand, this one-of-a-kind burn reversal solution now joins Theraderm's award-winning family of skin solutions.
  • Cool Skin then rapidly begins to reverse and repair any energy-caused burns after they happen, preventing permanent skin damage.
  • Plastic & Reconstructive Surgeon, Dr. James Beckman, CEO/founder of Therapon Skin Health, didn't envision starting a skin care company over two decades ago.

Global Benzophenone Market Outlook to 2026 - Featuring BASF, ADEKA and Clariant Among Others - ResearchAndMarkets.com

Wednesday, September 29, 2021 - 3:50pm

The Paints and Coatings segment is the biggest consumer of Benzophenone and is projected to drive the global market.

Key Points: 
  • The Paints and Coatings segment is the biggest consumer of Benzophenone and is projected to drive the global market.
  • Benzophenone acts by changing the conformational structure, emitting higher wavelengths, and converting UV light into heat.
  • Benzophenone works by altering the structural structure of ultraviolet light, emitting it at a longer wavelength, and converting it to heat.
  • Additionally, Benzophenone can be used for acidic rain applications or acid-catalyzed systems, thus driving the growth in the region.

Krystal Biotech to Present Data on DEB and B-VEC at the DEBRA International Conference 2021

Thursday, September 9, 2021 - 1:00pm

PITTSBURGH, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (Krystal) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced that it will present data on its lead product candidate beremagene geperpavec (B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB) at the upcoming DEBRA International Conference 2021.

Key Points: 
  • PITTSBURGH, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (Krystal) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced that it will present data on its lead product candidate beremagene geperpavec (B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB) at the upcoming DEBRA International Conference 2021.
  • Data to be presented includes preclinical evidence of safety and collagen VII expression after topical B-VEC application to induced corneal wounds.
  • In addition, the forward-looking statements included in this press release represent Krystals views as of the date of this release.
  • These forward-looking statements should not be relied upon as representing Krystals views as of any date subsequent to the date of this release.

DGAP-News: Medios AG: Accelerated roll-out of the digital platform mediosconnect

Wednesday, August 25, 2021 - 10:02am

Berlin, August 25, 2021 - Medios AG ("Medios"), the leading provider of Specialty Pharma Solutions in Germany, has launched its digital platform mediosconnect in a third German federal state.

Key Points: 
  • Berlin, August 25, 2021 - Medios AG ("Medios"), the leading provider of Specialty Pharma Solutions in Germany, has launched its digital platform mediosconnect in a third German federal state.
  • As a digital platform, mediosconnect connects physicians, specialized pharmacies and health insurance companies and simplifies ordering and billing processes for complex and individualized medicines.
  • Christoph Prueit, Chief Innovation Officer (CINO) of Medios AG: "We are pleased about the further roll-out of our platform mediosconnect.
  • Through the newly created position of Digital Health Manager at Medios AG, mediosconnect users also benefit from our comprehensive expertise.

DGAP-News: Medios AG: Falk Neukirch new CFO; term of office of Mi-Young Miehler and Christoph Prußeit extended prematurely

Monday, August 23, 2021 - 12:05pm

Berlin, August 23, 2021 - The Supervisory Board of Medios AG ("Medios") has appointed Falk Neukirch as a member of the Excecutive Board of Medios AG and as Chief Financial Officer (CFO) with effect from October 1, 2021.

Key Points: 
  • Berlin, August 23, 2021 - The Supervisory Board of Medios AG ("Medios") has appointed Falk Neukirch as a member of the Excecutive Board of Medios AG and as Chief Financial Officer (CFO) with effect from October 1, 2021.
  • Falk Neukirch holds a degree in business administration and looks back on around 25 years of experience in Corporate Finance at various companies.
  • By extending the contracts of Mi-Young Miehler and Christoph Prueit, we are creating continuity in the Executive Board team."
  • The Executive Board contracts of Mi-Young Miehler and Christoph Prueit were each extended prematurely until July 31, 2024.

DuPont™ Tedlar® Introduces PVF Laminated Metal Roofing Panels

Monday, August 9, 2021 - 2:00pm

WILMINGTON, Del., Aug. 9, 2021 /PRNewswire-PRWeb/ --DuPont (NYSE:DD) today announced it will showcase Tedlar PVF film for metal roofing, at the upcoming International Roofing Expo, August 10 - 12, 2021, at the Mandalay Bay Convention Center in Las Vegas, Nevada, booth 1135.

Key Points: 
  • WILMINGTON, Del., Aug. 9, 2021 /PRNewswire-PRWeb/ --DuPont (NYSE:DD) today announced it will showcase Tedlar PVF film for metal roofing, at the upcoming International Roofing Expo, August 10 - 12, 2021, at the Mandalay Bay Convention Center in Las Vegas, Nevada, booth 1135.
  • "Our recent North American launch of Tedlar film for laminating metal roofing and building wall panels has been extremely well received," Matt Urfali, Global DuPont Tedlar Sales & Marketing Director.
  • DuPont Tedlar polyvinyl fluoride (PVF) film laminated metal roofing was recently introduced to this market and is being sold exclusively by Titan Steel and its affiliated company, Metal Alliance in the North American and Caribbean markets.
  • Tedlar PVF film laminated metal surfaces can be found all around the world with decades of withstanding the elements.